Market Tracker

04/16 5:05pm ET

Repligen Corp (NASDAQ:RGEN)

15.40
Data as of Apr 16
 +1.03 / +7.17%
Today’s Change
7.37
Today|||52-Week Range
17.26
+12.90%
Year-to-Date

Today’s Trading

Previous close14.37
Today’s open15.61
Day’s range14.75 - 15.61
Volume1,213,070
Average volume (3 months)568,528
Market cap$438.3M
Dividend yield--
Data as of 3:59pm ET, 04/16/2014

Growth & Valuation

Earnings growth (last year)+11.11%
Earnings growth (this year)-60.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+9.48%
P/E ratio22.0
Price/Sales6.34
Price/Book4.20

Competitors

 Today’s
change
Today’s
% change
PETXAratana Therapeutics...+0.17+1.27%
TKMRTekmira Pharmaceutic...+1.23+9.65%
DVAXDynavax Technologies...+0.05+3.45%
XOMAXOMA Corp+0.12+2.86%
Data as of 3:59pm ET, 04/16/2014

Financials

Next reporting dateAugust 7, 2014
EPS forecast (this quarter)$0.04
Annual revenue (last year)$68.2M
Annual profit (last year)$16.1M
Net profit margin23.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Walter C. Herlihy
Senior Vice President-
Global Operations
Daniel P. Witt
Corporate headquarters
Waltham, Massachusetts

Forecasts